Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Nature Pub. Group
    • Subject Terms:
      COVID-19* ; Pandemics*; Anxiety/epidemiology ; China/epidemiology ; Cross-Sectional Studies ; Depression/epidemiology ; Humans ; India ; Japan ; Mental Health ; Prevalence ; SARS-CoV-2
    • Abstract:
      The coronavirus disease 2019 (COVID-19) pandemic has exposed humans to the highest physical and mental risks. Thus, it is becoming a priority to probe the mental health problems experienced during the pandemic in different populations. We performed a meta-analysis to clarify the prevalence of postpandemic mental health problems. Seventy-one published papers (n = 146,139) from China, the United States, Japan, India, and Turkey were eligible to be included in the data pool. These papers reported results for Chinese, Japanese, Italian, American, Turkish, Indian, Spanish, Greek, and Singaporean populations. The results demonstrated a total prevalence of anxiety symptoms of 32.60% (95% confidence interval (CI): 29.10-36.30) during the COVID-19 pandemic. For depression, a prevalence of 27.60% (95% CI: 24.00-31.60) was found. Further, insomnia was found to have a prevalence of 30.30% (95% CI: 24.60-36.60). Of the total study population, 16.70% (95% CI: 8.90-29.20) experienced post-traumatic stress disorder (PTSD) symptoms during the COVID-19 pandemic. Subgroup analysis revealed the highest prevalence of anxiety (63.90%) and depression (55.40%) in confirmed and suspected patients compared with other cohorts. Notably, the prevalence of each symptom in other countries was higher than that in China. Finally, the prevalence of each mental problem differed depending on the measurement tools used. In conclusion, this study revealed the prevalence of mental problems during the COVID-19 pandemic by using a fairly large-scale sample and further clarified that the heterogeneous results for these mental health problems may be due to the nonstandardized use of psychometric tools.
      (© 2021. The Author(s).)
    • References:
      Ann Intern Med. 2020 Aug 18;173(4):317-320. (PMID: 32251513)
      Asian J Psychiatr. 2020 Jun;51:102092. (PMID: 32315963)
      Gen Hosp Psychiatry. 2020 Nov-Dec;67:144-145. (PMID: 32381270)
      Brain Behav Immun. 2020 Aug;88:901-907. (PMID: 32437915)
      Int J Ment Health Nurs. 2020 Aug;29(4):549-552. (PMID: 32314526)
      Lancet Psychiatry. 2020 Jul;7(7):611-627. (PMID: 32437679)
      Int J Environ Res Public Health. 2020 Mar 06;17(5):. (PMID: 32155789)
      Nan Fang Yi Ke Da Xue Xue Bao. 2020 Feb 29;40(2):171-176. (PMID: 32376528)
      JAMA. 2020 Aug 4;324(5):439-440. (PMID: 32749496)
      Epidemiol Infect. 2020 May 20;148:e98. (PMID: 32430088)
      JAMA Netw Open. 2020 Mar 2;3(3):e203976. (PMID: 32202646)
      Int J Soc Psychiatry. 2020 Aug;66(5):504-511. (PMID: 32380879)
      Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
      Science. 2020 Aug 14;369(6505):818-823. (PMID: 32616673)
      Lancet Psychiatry. 2020 Apr;7(4):e19. (PMID: 32085843)
      Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Mar 20;38(3):192-195. (PMID: 32131151)
      BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
      J Med Internet Res. 2020 May 22;22(5):e19434. (PMID: 32401215)
      Psychiatry Res. 2020 Aug;290:113111. (PMID: 32450416)
      Psychiatry Res. 2020 Jun;288:112936. (PMID: 32276196)
      Psychol Health Med. 2021 Jan;26(1):23-34. (PMID: 32286091)
      Int J Environ Res Public Health. 2020 May 25;17(10):. (PMID: 32466251)
      Nat Rev Immunol. 2020 Jun;20(6):347-348. (PMID: 32346094)
      Psychother Psychosom. 2020;89(4):242-250. (PMID: 32272480)
      Diabetes Metab Syndr. 2020 Sep - Oct;14(5):779-788. (PMID: 32526627)
      Sleep Med. 2020 Aug;72:1-4. (PMID: 32502844)
      Sleep Med. 2020 Nov;75:12-20. (PMID: 32853913)
      Psychiatry Res. 2020 May;287:112934. (PMID: 32229390)
      EClinicalMedicine. 2020 Jun 24;24:100443. (PMID: 32766545)
      J Nutr Health Aging. 2020;24(5):456-458. (PMID: 32346678)
      Asian J Psychiatr. 2020 Jun;51:102083. (PMID: 32283510)
      J Affect Disord. 2020 Sep 1;274:1-7. (PMID: 32405111)
      Front Psychiatry. 2020 Apr 14;11:306. (PMID: 32346373)
      Occup Med (Lond). 2020 Jul 17;70(5):364-369. (PMID: 32372077)
      Acta Biomed. 2020 May 11;91(2):83-88. (PMID: 32420931)
      Med Sci Monit. 2020 Apr 26;26:e924609. (PMID: 32335579)
    • Publication Date:
      Date Created: 20210710 Date Completed: 20210714 Latest Revision: 20231107
    • Publication Date:
      20240628
    • Accession Number:
      PMC8266633
    • Accession Number:
      10.1038/s41398-021-01501-9
    • Accession Number:
      34244469